Melvin LK Chua

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Melvin LK Chua
May 25, 2025, 08:43 | Science
Melvin LK Chua: TIME delineates progression trajectories of distinct NPC phenotypes
Melvin LK CHUA, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared an article on X:…
Apr 22, 2025, 07:55 | Science
Melvin LK Chua: 1st part of Radiotherapy Series that deep dives into PORT for Head Neck cancer
Melvin LK Chua, Head of Department of Head Neck and Thoracic Cancers at National Cancer…
Apr 4, 2025, 09:46 | Blog
Melvin LK CHUA: An immense honour to be nominated as the Commissioner of ICRU
Melvin LK CHUA, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared a post on…
Feb 26, 2025, 16:30 | Blog
Reduced-volume vs conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma
Melvin LK Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared on X about…
Feb 21, 2025, 10:07 | Science
Elai Davicioni: Predicting Dose-Response to Prostate Cancer Radiotherapy
Elai Davicioni, Medical Director of Urology at Veracyte, posted on X about recent paper by…
Feb 19, 2025, 23:11 | Blog
Melvin LK Chua: Join the EUSICA INSICA - Brain meeting
Melvin LK Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared on X: "Join…
Jan 15, 2025, 07:31 | Science
Melvin LK Chua: Chromatin-related adaptation for acquired Radioresistance in Head and Neck Cancer
Melvin LK Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, shared an article by…
Jan 4, 2025, 14:10 | Insight
Melvin LK Chua: A monumental work to start 2025
Melvin LK Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, posted on X: “A…
Dec 25, 2024, 15:49 | Science
Melvin LK Chua: The mutational landscape of Radioresistant Cancers
Melvin LK Chua, Clinician-Scientist at the NCCS and Duke-NUS Medical School, posted on X about…
Dec 11, 2024, 14:33 | Blog
The importance of science and artistry in Radiotherapy planning in NPC
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Dec 10, 2024, 19:35 | Blog
New TNM staging system for nasopharyngeal cancer at ESMO Asia
Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of…
Nov 2, 2024, 03:04 | Blog
Melvin LK Chua: Potential Increased Risks of Toxicities with Combo IO Immunotherapy and RT
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Oct 13, 2024, 05:55 | Blog
Melvin LK CHUA: Developing the 9th Ver AJCC/UICC TNM Staging in NPC
Melvin LK CHUA, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Sep 11, 2024, 13:57 | Blog
Melvin LK Chua on the individualization of systemic therapies with radiotherapy in NPC at ESMO24
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Aug 27, 2024, 22:36 | Insight
Highlights from ESTRO meets Asia 2024 by Melvin LK Chua
The third edition of the Joint FARO-ESTRO Congress ESTRO meets Asia 2024 took place from…
Aug 24, 2024, 12:06 | Societies
Highlights from Day 2 of ESTRO Meets Asia 2024!
The “ESTRO Meets Asia 2024” conference is being held from August 23rd to 25th in Kuala…
Aug 9, 2024, 13:11 | Blog
Melvin LK Chua: This is why in person meetings are irreplaceable
The 2024 ASCO Breakthrough (ASCOBT24) meeting is bringing together the worldwide oncology community for three days…
Aug 6, 2024, 11:58 | Insight
Hidehito Horinouchi: ASCO Breakthrough 2024 is in 2 days
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
Jul 23, 2024, 00:20 | Blog
Melvin LK Chua: A meeting not to be missed and will only grow from strength to strength
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Jul 12, 2024, 17:13 | Blog
Melvin LK Chua: Join the meeting that covers the breath of Cancer Science
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Apr 3, 2024, 06:29 | Blog
Lillian Siu: Submit an abstract by 11:59 PM ET April 9 for ASCOBT24
Lillian Siu shared on X/Twitter: ''ASCOBT24, ASCO Aug 8-10, 2024 in Yokohama, Japan. Chaired by the…
Feb 28, 2024, 01:32 | Blog
Melvin LK Chua: Call me biased but would love to see Lillian Siu be the next AACR president-elect!
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Dec 4, 2023, 15:31 | Blog
Melvin LK Chua: Our commentary on the state of play of radiomics in Precision Oncology
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Nov 16, 2023, 17:09 | Blog
Melvin LK Chua: Planning for ASCOBT24 has started!
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Oct 21, 2023, 19:13 | Career
Melvin LK Chua: What a lecture East meets West by Prof Anthony Chan
Melvin LK Chua, Head of Department of Head Neck and Toracic Cancers, Division of Radiation…
Aug 4, 2023, 18:58 | Blog
Brainstorming on new initiatives for the region to improve access and outcomes for cancer care - Melvin LK Chua
Busy but productive day with the APACRC, ASCO as incoming Chair brainstorming on new initiatives…
Aug 4, 2023, 09:15 | Blog
10 Tweets from ASCOBT23 not to miss
ASCO Breakthrough (ASCOBT23) is being held in Yokohama, Japan, and online from August 3 to…
Aug 1, 2023, 18:49 | Blog
After a hiatus of 4 y, ASCO Breakthrough is finally back again this week - Melvin LK CHUA
After a hiatus of 4 y, ASCO Breakthrough is finally back again this week! Looking…
Jun 19, 2023, 18:18 | Career
I rejoined (best!) ASCO International Affairs Committee in capacity as Chair-Elect - Herbert Loong
As ASCO23 ends & we eagerly look forward to ASCO24, I am pleased to announce…
All: 29 Posts: 1 - 100
Special Coverage